DoD Neurofibromatosis, Exploration- Hypothesis Development Award | W81XWH 22 NFRP EHDA

Opportunity Information: Apply for W81XWH 22 NFRP EHDA

The DoD Neurofibromatosis Research Program (NFRP) Exploration - Hypothesis Development Award is a Department of Defense funding opportunity designed to jump-start new, bold ideas in neurofibromatosis (NF) research. Its main purpose is to support early-stage exploration of concepts that are innovative, high-risk, and potentially high-reward, with the expectation that the work will open up fresh directions for the field and provide a foundation for larger, follow-on studies. This mechanism is explicitly aimed at projects that could be groundbreaking rather than projects that simply extend or fine-tune what has already been published.

A central requirement is that the application proposes a clear, well-constructed, and testable hypothesis backed by strong scientific reasoning and a sound study design. Preliminary results and published supporting data are encouraged because they can strengthen the rationale, but they are not mandatory. That detail matters because it signals the program is willing to invest in well-justified ideas even when they are still at an exploratory stage, which is often the case for genuinely novel approaches. At the same time, the program is not looking for loosely formed concepts; the hypothesis and the way it will be tested still need to be rigorous and credible.

Innovation is the core evaluation theme for this award. Competitive projects are expected to introduce a new paradigm, challenge an existing assumption in NF research, bring a genuinely new viewpoint to an established problem, or otherwise demonstrate creative, unconventional thinking. The opportunity makes it clear that incremental advances on existing published work do not fit the intent of the mechanism. Because of this, the Principal Investigator has to directly and explicitly explain what makes the project innovative in the NF space, not just broadly interesting or technically competent. In practice, that usually means clearly stating what standard view or approach is being questioned, what new conceptual model or technique is being introduced, and why the new approach could substantially change understanding or treatment pathways if it succeeds.

The award also emphasizes modern expectations around data stewardship and reproducible science. Funded teams are expected to share data in alignment with the FAIR Data Principles, meaning the resulting datasets and related resources should be findable, accessible, interoperable, and reusable by others. Applicants are directed to follow the program's Data and Research Resources Sharing Plan guidance (referenced as an attachment in the full announcement). This focus indicates that, beyond generating intriguing early findings, the program wants projects to produce well-managed outputs that other researchers can discover, interpret, and build on, which is especially important for accelerating progress in complex disease areas like NF.

Administratively, this opportunity is issued by the Department of Defense, Department of the Army, through USAMRAA, and it falls under the Science and Technology/Research and Development funding category (CFDA 12.420). The funding instrument type listed includes both grants and cooperative agreements, meaning some awards may involve a more collaborative relationship with the funder depending on how a given project is structured and managed. Eligibility is described as unrestricted, so a broad range of applicant organizations may apply, subject to any additional eligibility notes in the full solicitation. The opportunity number is W81XWH 22 NFRP EHDA, it was originally posted April 11, 2022, and the original closing date was July 21, 2022. The announcement also indicated an expectation of about five awards, while the award ceiling was listed as 0, which typically signals that applicants need to consult the full program announcement for budget limits or that ceilings may be specified elsewhere rather than in the summary field.

Overall, the program is best understood as seed funding for NF research that is willing to take calculated scientific risks. The ideal application is one that pairs a daring, clearly differentiated idea with a disciplined plan to test it, explains in plain terms why it is truly novel for the NF field, and commits to sharing resulting data and resources in a way that others can reuse and validate.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Neurofibromatosis, Exploration- Hypothesis Development Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Apr 11, 2022.
• Applicants must submit their applications by Jul 21, 2022. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 5 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 22 NFRP EHDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: